Acino, a pharmaceutical company based in Switzerland, specializes in developing, producing, and globally selling well-established and innovative pharmaceuticals in new drug delivery formats. Acino is a leading expert in advanced drug delivery technologies, focusing on modified release oral forms, oral dispersible forms, transdermal systems, and extended release parenterals. Serving as a partner to pharmaceutical firms worldwide, Acino delivers finished in-house developed products and/or offers tailored end-to-end solutions ranging from product development and approval to contract manufacturing, packaging, and logistics. Operating under the brand Acino Switzerland, Acino markets high-quality Swiss medications in 80 countries across the Middle East, Africa, Latin America, and Asia.